Data Characteristics for This Category
Gene therapy AAV (adeno-associated virus) clinical trial pre-screening involves highly specialized and complex data. Data sources primarily include clinical trial registries (e.g., ClinicalTrials.gov), biomedical literature databases (e.g., PubMed, Embase), genomics and proteomics databases (e.g., NCBI Gene, UniProt), and drug development pipeline information platforms. These data sources have varying update frequencies. Clinical trial status changes can occur weekly, literature data updates monthly, and genomic data has a longer update cycle. Document structures typically include unstructured text (e.g., trial protocols, patient recruitment criteria, study result reports), semi-structured data (e.g., gene sequences, protein structures, dosage information in JSON or XML format), and structured data (e.g., patient characteristics, treatment groups, adverse event reports). Field and unit specificities include gene loci, AAV serotypes, vector dosages (e.g., vg/kg viral genomes per kilogram), target gene expression levels, and biomarker concentrations.
Constraints Imposed by These Characteristics on "Multi-turn Conversations and Prompts"
The specialized nature of AAV gene therapy data requires multi-turn conversation systems to accurately understand medical terminology, avoiding information deviations caused by synonyms or abbreviations. Inconsistent update frequencies mean the knowledge base needs a tiered update strategy to ensure the timeliness of critical clinical trial status information while balancing overall knowledge base maintenance costs. The complexity of document structures requires the conversation system to flexibly handle different data formats, for example, extracting key inclusion/exclusion criteria from unstructured text and associating it with structured data. The presence of specific fields and units, such as vg/kg, requires prompts to correctly identify and use these professional units when generating queries or answers. Failure to do so can lead to misinterpretations of dosage information. Furthermore, ethical considerations and regulatory requirements in the pre-screening process need guidance and constraints through prompts in multi-turn conversations to ensure compliance.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
maxContext | 8000 tokens | Accommodates detailed descriptions of gene therapy clinical trial protocols, retaining sufficient context to understand multi-turn conversation intent. |
Chunk size (Segment Length) | 500 characters (characters) | Balances long text understanding with retrieval efficiency, preventing loss of critical information within a single segment. |
Recall count (Retrieval Count) | Top 10 entries (top 10) | Ensures coverage of multiple relevant clinical trials or literature snippets under complex queries. |
Similarity threshold (Similarity Threshold) | 0.75 | Increases retrieval precision for highly specialized medical terminology, reducing interference from irrelevant information. |
Rerank result count (Reranked Return Count) | Top 5 entries (top 5) | Further optimizes ranking based on initial retrieval, improving the presentation priority of the most relevant information. |
Model Temperature | 0.3 | Reduces the randomness of model-generated content, ensuring accuracy and professionalism in answers, aligning with the rigorous requirements of clinical pre-screening. |
Three Common Mistakes
- JSON Schema fields are empty in conversation cards, leading to unexpected reply formats. This usually happens when the JSON Schema structure defined in the prompt does not match the actual model output capability, or the model fails to correctly parse and fill all required fields.
- The timestamp returned by the model conversation component in the workflow is incorrect or missing. The reason is usually that the time variable reference format in the prompt does not conform to platform specifications, or the
{{platform_time_variable}}provided by the platform is not correctly parsed into the current date. - The accuracy of pre-screening results significantly decreases after multi-turn conversations. This can be due to an outdated knowledge base, leading the model to make judgments based on obsolete information, or
maxContextbeing set too small, unable to accommodate complete patient medical history and trial criteria, resulting in critical information loss during the conversation.
How to Confirm Correct Configuration
- Simulate multi-turn conversations with typical patient characteristic descriptions, verifying that the model's output for inclusion/exclusion criteria judgment aligns with standard clinical guidelines.
- Use queries containing specific AAV dosages and serotype information to check if the model can accurately identify and cite relevant data from the knowledge base, and correctly present units, such as
vg/kg. - Randomly sample recently updated clinical trial data to verify if the model can make correct judgments by incorporating new information in multi-turn conversations, confirming the effectiveness of the knowledge base update strategy.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.